Press "Enter" to skip to content

New patent expiration for Eli Lilly drug ADCIRCA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Eli Lilly drug ADCIRCA

Annual Drug Patent Expirations for ADCIRCA
Annual Drug Patent Expirations for ADCIRCA

Adcirca is a drug marketed by Eli Lilly Co
and is included in one NDA. It is available from three suppliers. There are three patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in ADCIRCA is tadalafil. Three suppliers are listed for this compound. Additional details are available on the tadalafil profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Eli Lilly drug ADCIRCA
Do NOT follow this link or you will be banned from the site!